mRNA versus inactivated virus COVID-19 vaccines in multiple sclerosis: Humoral responses and protectivity

mRNA versus inactivated virus COVID-19 vaccines in multiple sclerosis: Humoral responses and protectivity—Does it matter?

Published:2023-07 Issue: Volume:75 Page:104761
ISSN:2211-0348
Container-title:Multiple Sclerosis and Related Disorders
language:en
Short-container-title:Multiple Sclerosis and Related Disorders

Author:

Tütüncü Melih^ORCID,Demir Serkan,Arslan Gökhan,Dinç Öykü,Şen Sedat,Gündüz Tuncay,Uzunköprü Cihat,Gümüş Haluk,Tütüncü Mesude,Akçin Rüveyda,Özakbaş Serkan,Köseoğlu Mesrure,Bünül Sena Destan,Gezen Ozan,Tezer Damla Çetinkaya,Baba Cavid,Özen Pınar Acar,Koç Rabia,Elverdi Tuğrul,Uygunoğlu Uğur,Kürtüncü Murat,Beckmann Yeşim,Doğan İpek Güngör,Turan Ömer Faruk,Boz Cavit,Terzi Murat,Tuncer Asli,Saip Sabahattin,Karabudak Rana,Kocazeybek Bekir,Efendi Hüsnü,Bilge Uğur,Siva Aksel

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology,General Medicine

Reference37 articles.

1. Abbott SARS-COV-2 IMMUNOASSAYS, https://www.corelaboratory.abbott/int/en/offerings/segments/infectious-disease/sars-cov-2.

2. Humoral immune response in multiple sclerosis patients following PfizerBNT162b2 COVID19 vaccination: up to 6 Months Cross-Sectional Study;Achiron;J. Neuroimmunol.,2021

3. Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies;Achiron;Ther. Adv. Neurol. Disord.,2021

4. Immune response to the third COVID-19 vaccine dose is related to lymphocyte count in multiple sclerosis patients treated with fingolimod;Achiron;J. Neurol.,2022

5. SARS-CoV-2 MRNA vaccination in people with multiple sclerosis treated with fingolimod: protective humoral immune responses may develop after the preferred third shot;Achtnichts;Vaccines (Basel),2022

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Homologous and Heterologous Covid-19 Booster Vaccinations Against SARS-CoV-2 Infection in the Elderly;Current Microbiology;2024-05-13

2. Long-Term Observation of SARS-CoV-2 Vaccination Response upon High Efficacy Treatment in Multiple Sclerosis—A Real-World Scenario;Vaccines;2024-03-12

3. Investigation of SARS-CoV-2 antibody levels after COVID-19 vaccine in chronic hepatitis B patients;Bratislava Medical Journal;2024

4. Outcomes of COVID-19 in kidney transplant recipients in the vaccination Era: A national multicenter cohort from Thailand;Heliyon;2023-12

5. Association of mRNA versus inactivated Covid-19 vaccine responses with smoking in Multiple Sclerosis;Archives of Neuropsychiatry;2023